Dow Up0.76% Nasdaq Up0.69%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
11.11 Up 0.78(7.55%) Oct 24, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 10,862   9,143   8,783   8,709  
Cost of Revenue198   -   -   -  
Gross Profit 10,664   9,143   8,783   8,709  
Operating Expenses
Research Development3,514  7,263  6,222  7,757  
Selling General and Administrative28,139  27,893  9,851  5,330  
Non Recurring -   -   -   -  
Others617  565  377  377  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (21,606) (26,578) (7,667) (4,755)
Income from Continuing Operations
Total Other Income/Expenses Net31  45  44  25  
Earnings Before Interest And Taxes(21,575)(26,533)(7,623)(4,730)
Interest Expense -   -   -   -  
Income Before Tax(21,575)(26,533)(7,623)(4,730)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(21,575)(26,533)(7,623)(4,730)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (21,575) (26,533) (7,623) (4,730)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (21,575) (26,533) (7,623) (4,730)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.